PT955064E - Processo para a producao de complexos de farmacos - Google Patents
Processo para a producao de complexos de farmacosInfo
- Publication number
- PT955064E PT955064E PT97924326T PT97924326T PT955064E PT 955064 E PT955064 E PT 955064E PT 97924326 T PT97924326 T PT 97924326T PT 97924326 T PT97924326 T PT 97924326T PT 955064 E PT955064 E PT 955064E
- Authority
- PT
- Portugal
- Prior art keywords
- spacer
- drug compound
- bound
- carboxyl groups
- polysaccharide derivative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14452296 | 1996-06-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT955064E true PT955064E (pt) | 2004-10-29 |
Family
ID=15364300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97924326T PT955064E (pt) | 1996-06-06 | 1997-06-05 | Processo para a producao de complexos de farmacos |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6291671B1 (pt) |
| EP (1) | EP0955064B1 (pt) |
| JP (1) | JP4137184B2 (pt) |
| CN (1) | CN1227034C (pt) |
| AT (1) | ATE273716T1 (pt) |
| AU (1) | AU723442B2 (pt) |
| CA (1) | CA2257233A1 (pt) |
| DE (1) | DE69730352T2 (pt) |
| DK (1) | DK0955064T3 (pt) |
| EA (1) | EA001897B1 (pt) |
| ES (1) | ES2229355T3 (pt) |
| ID (1) | ID17243A (pt) |
| NO (1) | NO323626B1 (pt) |
| PT (1) | PT955064E (pt) |
| TW (1) | TW409058B (pt) |
| WO (1) | WO1997046261A1 (pt) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW527183B (en) | 1996-06-06 | 2003-04-11 | Daiichi Seiyaku Co | Drug complex |
| CA2333321A1 (en) * | 1998-05-22 | 1999-12-02 | Daiichi Pharmaceutical Co., Ltd. | Drug complex |
| CA2412582A1 (en) * | 2000-06-29 | 2002-01-03 | Daiichi Pharmaceutical Co., Ltd. | Dds compound and process for the preparation thereof |
| EP1401875A4 (en) * | 2001-05-04 | 2005-01-26 | Univ Utah Res Found | HYALURONIC ACID-CONTAINING BIOKON JUGATES: TARGETED DELIVERY OF ANTIBODIES TO CANCER CELLS |
| US20030049253A1 (en) * | 2001-08-08 | 2003-03-13 | Li Frank Q. | Polymeric conjugates for delivery of MHC-recognized epitopes via peptide vaccines |
| US20050169883A1 (en) * | 2002-05-06 | 2005-08-04 | Prestwich Glenn D. | Preblocking with non-ha gags increases effectiveness of ha conjugated anticancer agents |
| US7691830B2 (en) * | 2005-02-17 | 2010-04-06 | Clive Elson | Method and composition for treatment of a mucosal tissue disorder |
| BRPI0611535B1 (pt) | 2005-05-05 | 2021-11-30 | Sensient Flavors Inc | Método para processar células de levedura para produzir beta-glucanos e mananas |
| US8354392B2 (en) | 2005-07-06 | 2013-01-15 | Seikagaku Corporation | Drug-introduced photo-crosslinked hyaluronic acid derived gel |
| ITPD20050242A1 (it) | 2005-08-03 | 2007-02-04 | Fidia Farmaceutici | Bioconiugati antitumorali dell'acido ialuronico o dei suoi derivati, ottenibili per coniugazione chimica diretta o indiretta, e loro impiego in campo farmaceutico |
| CN1973902B (zh) * | 2006-12-12 | 2010-11-10 | 东北师范大学 | 以人参多糖为载体的抗肿瘤药物阿霉素复合物及制备方法 |
| WO2011150022A2 (en) | 2010-05-25 | 2011-12-01 | Syndevrx, Inc. | Polymer-conjugated metap2 inhibitors, and therapeutic methods of use thereof |
| US9895449B2 (en) | 2010-05-25 | 2018-02-20 | Syndevrx, Inc. | Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof |
| SMT202000138T1 (it) | 2012-10-11 | 2020-05-08 | Daiichi Sankyo Co Ltd | Raccordi per coniugati anticorpo-farmaco |
| US9872924B2 (en) | 2012-10-19 | 2018-01-23 | Daiichi Sankyo Company, Limited | Antibody-drug conjugate produced by binding through linker having hydrophilic structure |
| EA033912B1 (ru) | 2013-04-10 | 2019-12-09 | Синдевркс, Инк. | ИНГИБИТОРЫ MetAP2 И СПОСОБЫ ЛЕЧЕНИЯ ОЖИРЕНИЯ |
| WO2015071841A1 (en) | 2013-11-12 | 2015-05-21 | Druggability Technologies Holdings Limited | Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| CN111228510B (zh) | 2013-12-25 | 2024-06-18 | 第一三共株式会社 | 抗trop2抗体-药物偶联物 |
| EP4464707A2 (en) | 2014-01-31 | 2024-11-20 | Daiichi Sankyo Company, Limited | Anti-her2 antibody-drug conjugate |
| RS61711B1 (sr) | 2014-04-10 | 2021-05-31 | Daiichi Sankyo Co Ltd | Anti-her3 antitelo-lek konjugat |
| US11185594B2 (en) | 2014-04-10 | 2021-11-30 | Daiichi Sankyo Company, Limited | (Anti-HER2 antibody)-drug conjugate |
| CA2990572C (en) | 2015-06-29 | 2022-07-26 | Daiichi Sankyo Company, Limited | Method for selectively manufacturing antibody-drug conjugate |
| CA3005450A1 (en) | 2015-12-10 | 2017-06-15 | Syndevrx, Inc. | Fumagillol derivatives and polymorphs thereof |
| CA3239447A1 (en) | 2016-01-11 | 2017-07-20 | Syndevrx, Inc. | Treatment for tumors driven by metabolic dysfunction |
| TWI862473B (zh) | 2016-12-12 | 2024-11-21 | 日商第一三共股份有限公司 | 抗體-藥物結合物與免疫檢查點抑制劑之組合、以及醫藥組成物之用途 |
| IL268102B2 (en) | 2017-01-17 | 2024-12-01 | Daiichi Sankyo Co Ltd | Anti-GPR 20 antibody and anti-GPR 20 antibody-drug conjugate |
| TWI855528B (zh) | 2017-05-15 | 2024-09-11 | 日商第一三共股份有限公司 | 抗體-藥物結合物之製造方法 |
| CA3073924C (en) | 2017-08-31 | 2023-10-17 | Daiichi Sankyo Company, Limited | Improved method for producing antibody-drug conjugate |
| KR102422860B1 (ko) | 2017-08-31 | 2022-07-19 | 다이이찌 산쿄 가부시키가이샤 | 항체-약물 콘주게이트의 신규 제조 방법 |
| PL3794042T3 (pl) | 2018-05-18 | 2024-06-10 | Daiichi Sankyo Co., Ltd. | Koniugat przeciwciało-lek przeciwciało skierowane przeciwko muc1 - eksatekan |
| TW202415410A (zh) | 2018-07-31 | 2024-04-16 | 日商第一三共股份有限公司 | 抗體-藥物結合物之用途 |
| CN113453721A (zh) | 2018-10-26 | 2021-09-28 | 辛德弗雷克斯公司 | Metap2抑制剂的生物标志物及其应用 |
| PH12022550037A1 (en) | 2019-07-10 | 2023-04-12 | Cybrexa 3 Inc | Peptide conjugates of microtubule-targeting agents as therapeutics |
| CN114341162A (zh) | 2019-07-10 | 2022-04-12 | 赛博克萨2公司 | 作为治疗剂的细胞毒素的肽缀合物 |
| US11806405B1 (en) | 2021-07-19 | 2023-11-07 | Zeno Management, Inc. | Immunoconjugates and methods |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5746920A (en) * | 1980-09-03 | 1982-03-17 | Kyosei Seiyaku Kk | Drug for digestive tract |
| GB2093697A (en) | 1980-09-03 | 1982-09-08 | Kyosei Pharmaceutical Co Ltd | Agent for alimentary canal |
| JPS59220197A (ja) * | 1983-05-30 | 1984-12-11 | Snow Brand Milk Prod Co Ltd | 新規な含窒素多糖体およびその製造方法 |
| JP2604930B2 (ja) | 1990-12-14 | 1997-04-30 | 株式会社ディ・ディ・エス研究所 | ヒアルロン酸およびコンドロイチン誘導体 |
| CA2059693C (en) * | 1991-01-28 | 2003-08-19 | Peter J. Kniskern | Polysaccharide antigens from streptococcus pneumoniae |
| CA2081025A1 (en) | 1991-02-21 | 1992-08-22 | Kazuhiro Inoue | Carboxymethylmannoglucans and derivatives thereof |
| JP3359955B2 (ja) | 1992-07-16 | 2002-12-24 | 第一製薬株式会社 | 抗腫瘍剤 |
| CA2134348C (en) | 1993-02-26 | 2007-01-02 | Hideo Nogusa | Polysaccharide derivatives and drug carriers |
| JPH0784481A (ja) | 1993-06-26 | 1995-03-31 | Ricoh Co Ltd | 画像形成装置 |
| SG50747A1 (en) | 1995-08-02 | 1998-07-20 | Tanabe Seiyaku Co | Comptothecin derivatives |
| TW527183B (en) | 1996-06-06 | 2003-04-11 | Daiichi Seiyaku Co | Drug complex |
| US6299881B1 (en) * | 1997-03-24 | 2001-10-09 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts |
-
1997
- 1997-05-31 TW TW086107456A patent/TW409058B/zh not_active IP Right Cessation
- 1997-06-05 JP JP50042298A patent/JP4137184B2/ja not_active Expired - Fee Related
- 1997-06-05 US US09/147,341 patent/US6291671B1/en not_active Expired - Fee Related
- 1997-06-05 PT PT97924326T patent/PT955064E/pt unknown
- 1997-06-05 CA CA002257233A patent/CA2257233A1/en not_active Abandoned
- 1997-06-05 WO PCT/JP1997/001915 patent/WO1997046261A1/ja active IP Right Grant
- 1997-06-05 AT AT97924326T patent/ATE273716T1/de not_active IP Right Cessation
- 1997-06-05 CN CNB971971153A patent/CN1227034C/zh not_active Expired - Fee Related
- 1997-06-05 AU AU29788/97A patent/AU723442B2/en not_active Ceased
- 1997-06-05 EA EA199900002A patent/EA001897B1/ru not_active IP Right Cessation
- 1997-06-05 DE DE69730352T patent/DE69730352T2/de not_active Expired - Lifetime
- 1997-06-05 ID IDP971929A patent/ID17243A/id unknown
- 1997-06-05 EP EP97924326A patent/EP0955064B1/en not_active Expired - Lifetime
- 1997-06-05 ES ES97924326T patent/ES2229355T3/es not_active Expired - Lifetime
- 1997-06-05 DK DK97924326T patent/DK0955064T3/da active
-
1998
- 1998-12-04 NO NO19985667A patent/NO323626B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0955064A1 (en) | 1999-11-10 |
| US6291671B1 (en) | 2001-09-18 |
| ID17243A (id) | 1997-12-11 |
| DK0955064T3 (da) | 2004-12-06 |
| NO985667D0 (no) | 1998-12-04 |
| JP4137184B2 (ja) | 2008-08-20 |
| ATE273716T1 (de) | 2004-09-15 |
| CN1227034C (zh) | 2005-11-16 |
| EP0955064A4 (en) | 2000-12-06 |
| EA199900002A1 (ru) | 1999-08-26 |
| WO1997046261A1 (en) | 1997-12-11 |
| AU723442B2 (en) | 2000-08-24 |
| EP0955064B1 (en) | 2004-08-18 |
| CA2257233A1 (en) | 1997-12-11 |
| CN1227500A (zh) | 1999-09-01 |
| NO985667L (no) | 1999-02-04 |
| DE69730352D1 (de) | 2004-09-23 |
| AU2978897A (en) | 1998-01-05 |
| DE69730352T2 (de) | 2005-09-08 |
| NO323626B1 (no) | 2007-06-18 |
| TW409058B (en) | 2000-10-21 |
| EA001897B1 (ru) | 2001-10-22 |
| ES2229355T3 (es) | 2005-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT955064E (pt) | Processo para a producao de complexos de farmacos | |
| BR9403499A (pt) | Processo e sistema catalítico para produção de ácido acético | |
| DE59006824D1 (de) | Verfahren zum immobilisieren von proteinen, peptiden, coenzymen od.dgl. an einem träger. | |
| DE69830507D1 (de) | Verfahren zur herstellung organischer boronsäurederivate mit hilfe von diboronsäure | |
| BR0009762A (pt) | Catalisador para produção de ácido acético ou ácido acético e acetato de etila, processo para sua produção e processo para produção de ácido acético ou ácido acético e acetato de etila usando-o | |
| DE69900462D1 (de) | Konjugate von dns und pns und verfahren zu deren herstellung | |
| ATE342316T1 (de) | Verfahren zur herstellung von mikroperlen die fettlösliche substanzen enthalten | |
| HU9301765D0 (en) | Compounds of cerium (iv) as well as their production and application | |
| ATE239001T1 (de) | Verfahren zur herstellung von triazolinthion- derivaten | |
| ATE299858T1 (de) | Verfahren zur herstellung von diaminodiphenylmethan und seiner höheren homologen | |
| BR9100921A (pt) | Processo para preparacao de precursor de amicacina e composto de 3,6'-di-n-acil-canamicina a potonizada | |
| EP1063232A3 (en) | Process for producing erythro-3-amino-2-hydroxybutyric acid derivatives | |
| RU93004665A (ru) | Микробиологический способ гидроксилирования азот-гетероциклических-карбоновых кислот | |
| BR9811579B1 (pt) | ácidos 3-ciano-2,4-dialógeno-5-fluorobenzóicos e processo para a preparação dos mesmos. | |
| EP0344791A3 (en) | Process for the enzymatic resolution of the optical isomers of racemic ester derivatives of 3-mercapto-2-alkyl-propionic acid | |
| ATE107691T1 (de) | Biokatalysatoren und verfahren zu ihrer herstellung. | |
| PT1109782E (pt) | Processo para a producao de acidos azetidino-2-carboxilicos (azeoh) protegidos em n | |
| GR3002989T3 (en) | Process for the production of n-acylated mercapto-alpha-amino acids | |
| FI885638A (fi) | Menetelmä lääkeaineina käyttökelpoisten griseoliinihappomonoesterijohdannaisten valmistamiseksi | |
| IT1233862B (it) | Processo catalitico per la sintesi di esteri di acidi etilentetracarbossilici. | |
| WO1995019341A3 (en) | Process for making 5-nitrobarbituric acid and salts thereof | |
| TH26735A (th) | กระบวนการสำหรับการลดคอนเทนต์ผลพลอยได้ของคาร์เบนเดซิม | |
| RU95115861A (ru) | Способ получения мурамилпептидов | |
| TH31339A (th) | วิธีเตรียมยาเชิงซ้อน |